For clients needing prescription refills whom have completed their consultation and been initiated on therapy. 

Semaglutide is a FDA approved injection for medically supervised weight loss in adults with obesity and weight-related health conditions. This GLP-1 agonist works to reduce cravings and appetite while improving blood sugar levels. Treatment is recommended for individuals with a BMI > 27 and risk factors for obesity related complications OR BMI > 30 whom wishes to pursue pharmacologic options for weight loss. Consultation is required prior to beginning weight loss therapy. 

For clients needing prescription refills whom have completed their consultation and been initiated on therapy.